Understanding the pathology of vascular cognitive impairment

Kurt A Jellinger1

  • 1Institute of Clinical Neurobiology, Kenyongasse 18, A-1070 Vienna, Austria. kurt.jellinger@univie.ac.at

Insights

Vascular dementia (VaD), now vascular cognitive impairment (VCI), and mixed dementia lack clear diagnostic criteria. Research suggests differing lesion patterns and pathogenesis for pure VCI versus mixed dementia.

Area of Science:

  • Neurology
  • Pathology
  • Geriatrics

Background:

  • Vascular dementia (VaD), now termed vascular cognitive impairment (VCI), and mixed dementia lack validated neuropathologic criteria.
  • VCI is suggested in 8-10% of cognitively impaired elderly in memory clinics, with autopsy prevalence varying widely (0.03%-58%).
  • Cerebrovascular lesions (CVL) are associated with cognitive impairment, but their specific role and interaction with Alzheimer's disease pathology require further study.

Purpose of the Study:

  • To discuss the prevalence, morphology, and pathogenesis of vascular dementia (VaD)/vascular cognitive impairment (VCI) and mixed dementia.
  • To differentiate the neuropathologic features of pure VCI from mixed dementia.
  • To explore the impact of cerebrovascular lesions on cognitive decline, particularly in relation to Alzheimer's disease.

Main Methods:

  • Review of memory clinic and autopsy series data on VaD/VCI prevalence.
  • Analysis of lesion patterns (microinfarcts, lacunes, large infarcts) in different dementia types.
  • Comparison of neuropathologic findings in pure VCI versus mixed dementia (Alzheimer's disease + vascular encephalopathy).

Main Results:

  • VaD/VCI prevalence varies significantly between clinical and autopsy studies.
  • Pure VCI is often associated with small, subcortical lesions from microangiopathies, differing from mixed dementia's frequent large infarcts.
  • Minor CVL may not be essential for Alzheimer's disease cognitive decline, but mild AD pathology and small vessel disease can interact synergistically.

Conclusions:

  • Validated diagnostic criteria for VCI are needed.
  • The pathogenesis of pure VCI appears distinct from mixed dementia.
  • Further research is required to clarify the impact of vascular lesions on cognitive impairment and their interaction with Alzheimer's disease pathology.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...